ADR — Adherium Share Price
Last Trade - 00:00- AU$10.87m
- AU$10.70m
- AU$1.07m
Momentum
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | |||
| EPS Growth (f) | |||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | |||
| Price to Tang. Book | |||
| Price to Free Cashflow | |||
| Price to Sales | |||
| EV to EBITDA | |||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | |||
| Return on Equity | |||
| Operating Margin | |||
Financial Summary
| Year End 30th Jun | Unit | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | AU$m | 3.19 | 2.96 | 6.17 | 2.85 | 2.23 | n/a | n/a | -5.14% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Health trend(F-Score)
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Adherium Limited is principally engaged in the development, manufacture and supply of its Smartinhaler digital health technologies, which address sub-optimal medication use and improve health outcomes in chronic disease. It offers a range of smart devices for respiratory medications globally. Its Smartinhaler platform supports asthma and chronic obstructive pulmonary disease (COPD) medication adherence solution. The Bluetooth enabled Smartinhaler medication sensors wrap around patients existing inhalers and automatically send usage data to their smartphone. The Smartinhaler application enables patients and healthcare professionals to track medication adherence, set daily reminders, and discover insights into their medication usage. Its application also enables real-time reporting, monitoring, storing and analysis of inhaler use. The SmartinhalerLive platform uses wireless communications technology to provide real time data collection and reporting from the its Smartinhalers.
Directors
- James Ward-Lilley (52)
- Rick Legleiter (61)
- Anne Bell
- Geoff Feakes
- Rob Turnbull VFN
- Timothy Houchin
- Vik Panda
- Julia Chambers
- Nigel Devine
- Jane Lapon
- Bronwyn Le Grice OTH
- Chris Mander
- Maggie Scott
- Mark Licciardo
- George Baran
- Jeremy Curnock-Cook NED (70)
- William Hunter
- Matthew McNamara
- Bruce McHarrie (55)
- Last Annual
- June 30th, 2020
- Last Interim
- December 31st, 2020
- Incorporated
- April 17th, 2015
- Public Since
- August 26th, 2015
- No. of Shareholders
- 680
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Australian Stock Exchange - SEATS
- Shares in Issue
- 679,596,011
- Address
- Level 11, 16 Kingston Street, AUCKLAND, 1010
- Web
- http://adherium.com/
- Phone
- +64 93072771
- Auditors
- PricewaterhouseCoopers
Latest News for ADR
Upcoming events for ADR
Full Year 2021 Adherium Ltd Earnings Release
Adherium Ltd Annual Shareholders Meeting
Similar to ADR
4DMEDICAL ORD
Australian Stock Exchange - SEATS
ATOMO DIAGNOSTICS ORD
Australian Stock Exchange - SEATS
BLUECHIIP ORD
Australian Stock Exchange - SEATS
CARDIEX ORD
Australian Stock Exchange - SEATS
COMPUMEDICS ORD
Australian Stock Exchange - SEATS
FAQ
As of Today at 19:56 UTC, shares in Adherium are trading at AU$0.02. This share price information is delayed by 15 minutes.
Shares in Adherium last closed at AU$0.02 and the price had moved by -40.74% over the past 365 days. In terms of relative price strength the Adherium share price has underperformed the ASX All Ordinaries Index by -53.05% over the past year.
The overall consensus recommendation for Adherium is Strong Sell. You can view the full broker recommendation list by unlocking its StockReport.
Adherium does not currently pay a dividend.
Adherium does not currently pay a dividend.
Adherium does not currently pay a dividend.
To buy shares in Adherium you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of AU$0.02, shares in Adherium had a market capitalisation of AU$10.87m.
Here are the trading details for Adherium:
- Country of listing: Australia
- Exchange: ASX
- Ticker Symbol: ADR
Based on an overall assessment of its quality, value and momentum Adherium is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Adherium is AU$0.01. That is 37.5% below the last closing price of AU$0.02.
Analysts covering Adherium currently have a consensus Earnings Per Share (EPS) forecast of for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Adherium. Over the past six months, its share price has underperformed the ASX All Ordinaries Index by -27.07%.
As of the last closing price of AU$0.02, shares in Adherium were trading -23.1% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
We are not able to find PE ratio data for Adherium.
Adherium's management team is headed by:
- James Ward-Lilley -
- Rick Legleiter -
- Anne Bell -
- Geoff Feakes -
- Rob Turnbull - VFN
- Timothy Houchin -
- Vik Panda -
- Julia Chambers -
- Nigel Devine -
- Jane Lapon -
- Bronwyn Le Grice - OTH
- Chris Mander -
- Maggie Scott -
- Mark Licciardo -
- George Baran -
- Jeremy Curnock-Cook - NED
- William Hunter -
- Matthew McNamara -
- Bruce McHarrie -
We do not have data on Adherium's shareholders